文献速递中枢神经肿瘤放疗姑息放疗与转移瘤

分阶段伽玛刀治疗大体积脑转移瘤的局部控制及全身治疗影响

Staged Gamma Knife radiosurgery for large brain metastases: local control and the influence of systemic treatment.
PubMed 文献 · Radiother Oncol · 2025-09-08

回顾性队列纳入295例未接受过脑部局部治疗的大体积脑转移瘤患者,评估分阶段伽玛刀放疗(SGKRS)的颅内局部控制。12个月局部控制概率83%,总生存39%;同步或辅助全身治疗及分次间体积缩小与更好局部控制相关,而全部治疗病灶总体积更大则与更差局部控制相关;12个月症状性放射性脑坏死概率26%。

要点

  • SGKRS治疗后12个月颅内局部控制概率83%,总生存仅39%。
  • 同步/辅助全身治疗与更好局部控制相关(aHR 0.30,95%CI 0.15-0.61)。
  • 分次间体积缩小与更好局部控制相关,全部病灶总体积更大则更差。

核心结论

  • SGKRS对大体积脑转移瘤可获得较高的颅内局部控制,加用全身治疗可进一步改善局部控制,但总生存仍有限,需重视合适患者选择。

研究设计与样本

  • 回顾性队列研究,纳入295例既往未接受脑部局部治疗、接受SGKRS的大体积脑转移瘤患者。
  • 主要终点为12个月颅内局部控制概率,采用Kaplan-Meier法计算,并用单因素和多因素Cox回归分析相关变量。

主要发现

  • 12个月颅内局部控制概率为83%,12个月总生存为39%。
  • 多因素Cox回归显示,接受任何类型同步或辅助全身治疗与更好颅内局部控制显著相关(aHR 0.30,95%CI 0.15-0.61)。
  • 第一与第二分次间体积缩小与更好颅内局部控制显著相关(aHR 0.99,95%CI 0.98-0.998)。
  • 全部治疗脑转移瘤总体积更大与更差颅内局部控制显著相关(aHR 1.02,95%CI 1.01-1.04)。
  • 12个月症状性放射性脑坏死概率为26%。

临床怎么用

  • 对大体积脑转移瘤可考虑SGKRS以获得较高局部控制。
  • 综合评估是否联合同步或辅助全身治疗,以潜在改善局部控制。
  • 关注全部治疗病灶总体积及分次间体积变化对局部控制的影响。
  • 因总生存有限,应重视合适患者选择并权衡放射性脑坏死风险。

局限性

  • 本研究为回顾性队列研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Staged Gamma Knife radiosurgery (SGKRS) delivers high-dose radiotherapy to large brain metastases (BM) in two or three fractions with a time interval of several weeks. Various systemic treatments have also demonstrated favorable intracranial responses. Therefore, the outcome of patients undergoing radiosurgery and systemic treatment for large BM is of high interest but unknown. MATERIALS AND METHODS: A retrospective cohort study was conducted on patients with large BM treated with SGKRS without previous local treatment directed to the brain. The primary outcome measure was the probability of intracranial local control at 12 months, calculated by the Kaplan-Meier method. Univariable and multivariable Cox regression analyses were performed to identify variables associated with intracranial local control. RESULTS: 295 patients were included. Intracranial local control probability at 12 months was 83 % and overall survival at 12 months was 39 %. In the multivariable Cox regression analysis, receiving any type of concurrent or adjuvant systemic treatment (adjusted hazard ratio [aHR] 0.30, 95 % confidence interval [CI] 0.15-0.61) and volume reduction between the first and second fraction (aHR 0.99, 95 % CI 0.98-0.998) were significantly associated with better intracranial local control. Larger total volume of all treated BM (aHR 1.02, 95 % CI 1.01-1.04) was significantly associated with worse intracranial local control. The probability of symptomatic cerebral radiation necrosis at 12 months was 26 %. CONCLUSION: SGKRS results in high local control, with further improvement when systemic treatment is administered. However, overall survival remains limited, highlighting the importance of adequate patient selection.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Huisman RG, van Schie P, Merckel LG, et al. Staged Gamma Knife radiosurgery for large brain metastases: local control and the influence of systemic treatment. Radiother Oncol. 2025. PMID: 40930277. doi:10.1016/j.radonc.2025.111127

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。